Evidence map›Paper›PMID 38469056›Full record

ArticleInternational journal of nanomedicine2024

Glutathione Depletion-Induced ROS/NO Generation for Cascade Breast Cancer Therapy and Enhanced Anti-Tumor Immune Response.

Jing Wang, Yanxiang Sang, Weijian Chen, Liang Cheng, Wenxiang Du, Hongjie Zhang, Benyan Zheng, Lei Song, Yuan Hu, Xiaopeng Ma

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jing Wang *Department of General Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.
Yanxiang Sang *State Key Laboratory of Fire Science, University of Science and Technology of China, Hefei, Anhui, 230006, People's Republic of China.
Weijian ChenTechnology Center, China Tobacco Anhui Industrial Co, Ltd, Hefei, Anhui, 230088, People's Republic of China.
Liang ChengState Key Laboratory of Fire Science, University of Science and Technology of China, Hefei, Anhui, 230006, People's Republic of China.
Wenxiang DuState Key Laboratory of Fire Science, University of Science and Technology of China, Hefei, Anhui, 230006, People's Republic of China.
Hongjie ZhangState Key Laboratory of Fire Science, University of Science and Technology of China, Hefei, Anhui, 230006, People's Republic of China.
Benyan ZhengState Key Laboratory of Fire Science, University of Science and Technology of China, Hefei, Anhui, 230006, People's Republic of China.
Lei SongState Key Laboratory of Fire Science, University of Science and Technology of China, Hefei, Anhui, 230006, People's Republic of China.
Yuan HuState Key Laboratory of Fire Science, University of Science and Technology of China, Hefei, Anhui, 230006, People's Republic of China.
Xiaopeng MaDepartment of General Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China.
University of Science and Technology of China · CNChina Tobacco · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: As an effective alternative choice to traditional mono-therapy, multifunctional nanoplatforms hold great promise for cancer therapy. Based on the strategies of Fenton-like reactions and reactive oxygen species (ROS)-mediated therapy, black phosphorus (BP) nanoplatform BP@Cu Methods: Cu Results: Cu Discussion: BCL nanoparticles exhibited multifunctional characteristics for GSH depletion-induced ROS/NO generation, making a new multitherapy strategy for cascade breast cancer therapy.

Indexed as

NanoparticlesNeoplasmsArginineCell Line, TumorGlutathioneHumansHydrogen PeroxideNitric OxideReactive Oxygen SpeciesTumor MicroenvironmentArginineGlutathioneHydrogen PeroxideNitric OxideReactive Oxygen Speciesblack phosphoruschemodynamic therapycombination cancer therapynitric oxide gas therapysonodynamic therapy

Identifiers

PMID38469056
PMCPMC10926878
OpenAlexW4392613026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.